Skip to content

Effect of Ventilation Tubes in Otitis-prone Children

Ventilation Tubes for Recurrent Acute Otitis Media - Effects on Antibiotic Consumption and Otitis Media Episodes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05348291
Enrollment
150
Registered
2022-04-27
Start date
2022-10-21
Completion date
2033-05-31
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Acute Otitis Media

Keywords

ventilation tubes, prevention, quality of life, antibiotic treatment, otitis media with effusion, audiometry, watchful waiting, tympanic membrane perforation

Brief summary

The purpose of this study is to investigate the effects of ventilation tubes in children with recurrent ear infections. By drawing lots, young children with recurrent ear infections will be assigned to one of two groups (ventilation tubes or close follow-up), and the number of ear infections and antibiotic prescriptions in each group will be monitored. The study participants will be followed until they are 7 years old.

Detailed description

Children who fulfil the criteria of recurrent acute otitis media (AOM) before they are one year of age will be randomised to ventilation tube surgery or active monitoring (50% vs 50%). Due to the nature of the intervention, blinding will not be possible. Children randomised to are randomised to active monitoring and continue to have frequent recurrences will be given the opportunity to cross between groups. Children will be followed by the study doctors every third month until the age of two years, and after this yearly. In addition to planned visits, the families will be advised to contact the study doctors whenever they suspect that their child has a new episode of AOM. Otomicroscopy and nasopharyngeal cultures will be performed at every visit; cultures from the external ear canal will be taken when applicable. It will also be noted whether there is any perforation of the tympanic membrane, whether ventilation tubes are still in place, whether there is an ongoing episode of AOM or of otitis media with effusion (OME). At each planned visit, a parental quality of life questionnaire for children with ear disease will be completed. It will be noted how many AOM episodes the child has had since the last planned visit, how many times the patient has been prescribed oral antibiotics (also for reasons other than AOM), and if the family has seen a doctor elsewhere. At each emergency visit, it will be noted if the child has AOM or not, whether the child has fever, any signs of complications to AOM, a spontaneous perforation and whether the child´s general well-being is affected. At the ages of 4 and 7 years and, if a hearing impairment is suspected on any other occasion, hearing tests will be performed.

Interventions

DEVICEventilation tubes

Transtympanic pressure equalising devices.

Sponsors

Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Unblinded, randomised controlled trial.

Eligibility

Sex/Gender
ALL
Age
1 Years to 2 Years
Healthy volunteers
No

Inclusion criteria

At inclusion, children should be under 1 year of age and fulfil the internationally accepted definition of recurrent AOM, ie have had 3 episodes of AOM during the last 6 months, or 4 during the last 12 months. \-

Exclusion criteria

chromosomal aberrations, cleft palate or severe immune deficiency \-

Design outcomes

Primary

MeasureTime frameDescription
Antibiotic prescriptionsFirst two years in studyNumber of oral antibiotic prescriptions
Otitis media episodesFirst two years in studyNumber of otitis media episodes

Secondary

MeasureTime frameDescription
MicrobiologyFirst two years in studyNasopharyngeal and middle ear growth during acute otitis media episodes
Tympanic membrane perforationsUntil age 7Presence of chronic tympanic membrane perforations
AudiometryAt age 4 and 7 yearsAudiometry, including high frequency audiometry

Countries

Sweden

Contacts

Primary ContactMarie Gisselsson-Solen, MD, PhD
marie.gisselsson-solen@med.lu.se+4646172815
Backup ContactAnn Hermansson, Professor
ann.hermansson@med.lu.se+4646171360

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026